Tags

Type your tag names separated by a space and hit enter

Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.
Pharmacoeconomics. 2000 Dec; 18(6):609-12.P

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comment
Letter

Language

eng

PubMed ID

11227398

Citation

Linkins, K W., et al. "Potential Savings in the Cost of Caring for Alzheimer's Disease. Treatment With Rivastigmine." PharmacoEconomics, vol. 18, no. 6, 2000, pp. 609-12.
Linkins KW, Lloyd JR, Hjelmstad GO, et al. Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. Pharmacoeconomics. 2000;18(6):609-12.
Linkins, K. W., Lloyd, J. R., Hjelmstad, G. O., & Strausbaugh, H. J. (2000). Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. PharmacoEconomics, 18(6), 609-12.
Linkins KW, et al. Potential Savings in the Cost of Caring for Alzheimer's Disease. Treatment With Rivastigmine. Pharmacoeconomics. 2000;18(6):609-12. PubMed PMID: 11227398.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. AU - Linkins,K W, AU - Lloyd,J R, AU - Hjelmstad,G O, AU - Strausbaugh,H J, PY - 2001/3/3/pubmed PY - 2001/4/3/medline PY - 2001/3/3/entrez SP - 609 EP - 12 JF - PharmacoEconomics JO - Pharmacoeconomics VL - 18 IS - 6 SN - 1170-7690 UR - https://www.unboundmedicine.com/medline/citation/11227398/Potential_savings_in_the_cost_of_caring_for_Alzheimer's_disease__Treatment_with_rivastigmine_ L2 - https://dx.doi.org/10.2165/00019053-200018060-00007 DB - PRIME DP - Unbound Medicine ER -